Atossa Therapeutics Ownership | Who Owns Atossa Therapeutics?


OverviewForecastRevenueFinancialsChart

Atossa Therapeutics Ownership Summary


Atossa Therapeutics is owned by 21.74% institutional investors, 0.06% insiders, and 78.20% retail investors. Blackrock is the largest institutional shareholder, holding 7.34% of ATOS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Atossa Therapeutics shares.

ATOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtossa Therapeutics21.74%0.06%78.20%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.20M7.34%$10.94M
Vanguard group6.49M5.18%$7.72M
Geode capital management2.77M2.21%$3.30M
State street1.66M1.33%$1.98M
Renaissance1.55M1.24%$1.85M
Morgan stanley456.15K0.36%$542.82K
Bank of new york mellon411.67K0.33%$489.88K
Charles schwab investment management369.99K0.30%$440.29K
Northern trust267.21K0.21%$317.98K
Jane street group260.08K0.21%$309.50K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Virtu financial75.13K0.01%$89.00K
Renaissance1.55M0.00%$1.85M
Lvm capital management ltd/mi21.00K0.00%$25.00K
Xtx topco24.66K0.00%$29.35K
Pfg investments23.65K0.00%$28.14K
Northrock partners16.75K0.00%$19.93K
Koss-olinger consulting15.00K0.00%$18.00K
J. l. bainbridge11.12K0.00%$13.23K
Connor, clark & lunn investment management209.24K0.00%$249.00K
St. johns investment management company1.55K0.00%$1.84K

Top Buyers

HolderShares% AssetsChange
Blackrock9.20M0.00%6.45M
Geode capital management2.77M0.00%1.56M
State street1.66M0.00%1.17M
Vanguard group6.49M0.00%731.88K
Bank of new york mellon411.67K0.00%399.04K

Top Sellers

HolderShares% AssetsChange
Laurion capital management lp---2.23M
Millennium management10.66K--1.00M
Goldman sachs group102.67K--525.89K
Morgan stanley456.15K--309.26K
Hrt financial lp---291.42K

New Positions

HolderShares% AssetsChangeValue
Nuveen asset management170.73K0.00%170.73K$203.17K
Rhumbline advisers135.12K0.00%135.12K$160.78K
New york state common retirement fund87.80K0.00%87.80K$104.00K
Corebridge financial68.05K0.00%68.05K$81.66K
Invesco57.90K-57.90K$68.90K

Sold Out

HolderChange
Nbc securities-150.00
Old point trust & financial services n a-250.00
Macquarie group-1.74K
Atria wealth solutions-10.00K
Alpine global management-12.17K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20249112.35%27,343,7514.42%214.98%37-22.92%2578.57%
Jun 30, 20248114.08%26,186,18535.76%208.82%4829.73%1344.44%
Mar 31, 20247142.00%19,288,84520.98%159.58%37236.36%9-43.75%
Dec 31, 202350-9.09%15,943,994-1.25%127.80%11-38.89%1614.29%
Sep 30, 2023553.77%16,145,7941.05%128.01%18-14.29%14-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.94M3.13%-
iShares Russell 2000 ETF3.52M2.80%-7.35K
Vanguard Institutional Extnd Mkt Idx Tr1.67M1.33%-
Fidelity Small Cap Index1.30M1.04%-689.00
iShares Russell 2000 Value ETF1.10M0.87%1.41K
Fidelity Extended Market Index691.60K0.55%-172.00
State St Russell Sm Cap® Indx SL Cl I578.00K0.46%-
Vanguard Russell 2000 ETF576.47K0.46%-3.60K
NT R2000 Index Fund - NL302.04K0.24%302.04K
Schwab Small Cap Index301.65K0.24%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 10, 2024Finn Jonathan-Buy$44.25K
Nov 15, 2023WEAVER GREGORY L Former EVP, CFO, & DirectorSell$32.50K
Jun 20, 2023WEAVER GREGORY L EVP & CFOBuy$48.50K
Jul 02, 2021WEAVER GREGORY L-Sell$599.83K
May 30, 2018Chen Shu-Chih-Buy$9.20K

Insider Transactions Trends


DateBuySell
2024 Q21-
2024 Q1--
2023 Q4-1
2023 Q21-
2023 Q1--

ATOS Ownership FAQ


Who Owns Atossa Therapeutics?

Atossa Therapeutics shareholders are primarily institutional investors at 21.74%, followed by 0.06% insiders and 78.20% retail investors. The average institutional ownership in Atossa Therapeutics's industry, Biotech Stocks , is 47.04%, which Atossa Therapeutics falls below.

Who owns the most shares of Atossa Therapeutics?

Atossa Therapeutics’s largest shareholders are Blackrock (9.2M shares, 7.34%), Vanguard group (6.49M shares, 5.18%), and Geode capital management (2.77M shares, 2.21%). Together, they hold 14.72% of Atossa Therapeutics’s total shares outstanding.

Does Blackrock own Atossa Therapeutics?

Yes, BlackRock owns 7.34% of Atossa Therapeutics, totaling 9.2M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 10.94M$. In the last quarter, BlackRock increased its holdings by 6.45M shares, a 234.28% change.

Who is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested?

Virtu financial is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 75.13K Atossa Therapeutics shares, valued at 89K$.

Who is the top mutual fund holder of Atossa Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Atossa Therapeutics shares, with 3.13% of its total shares outstanding invested in 3.94M Atossa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools